Related Experiment Video
Updated: Jan 9, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving
Cyrus Farazmand1, Pensiree Attaseth2, Hongming Zhuang2
1Department of Radiology, Hospital of University of Pennsylvania.
Inflammatory immune-related adverse events are known complications of immunotherapy, particularly checkpoint inhibitors. A 16-year-old girl with metastatic melanoma, treated with nivolumab, dabrafenib, and trametinib, presented with abdominal pain and vomiting. Initial CT suggested metastases, showing mesenteric stranding and targetoid lesions. FDG PET/CT confirmed increased FDG uptake in the same region, but subsequent MRI and follow-up findings pointed to mesenteric panniculitis.
Inflammatory immune-related adverse events are known complications of immunotherapy, particularly checkpoint inhibitors. A 16-year-old girl with metastatic melanoma, treated with nivolumab, dabrafenib, and trametinib, presented with abdominal pain and vomiting. Initial CT suggested metastases, showing mesenteric stranding and targetoid lesions. FDG PET/CT confirmed increased FDG uptake in the same region, but subsequent MRI and follow-up findings pointed to mesenteric panniculitis.
